Gesponsert
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Posted
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Search
Nach Verein filtern
- National
- International
- Business
- Technology
- Health
- Ausbildung
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
NEA chief Hitendra Dev Shakya dismisses load-shedding rumors as baseless
KATHMANDU: Executive Director of the Nepal Electricity Authority (NEA), Hitendra Dev...
Rishabh Pant hits out at rumours on his LSG future: 'Little sense...'
Rishabh Pant refuted social media rumors suggesting his release from the Lucknow Super Giants,...
'Ajith is the most wonderful person in our business’; Rahul
Rahul Dev recently opened up about his early days in the industry and how he kept receiving...
Sophie recalls facing casting couch
Sophie Choudhry revealed early career experiences where some industry individuals made...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Deutsch
